Biovail Declares Quarterly Dividend
Total Dividends Declared Since December 2005 of $4.88 per share
TORONTO--(BUSINESS WIRE)--Feb. 26, 2009--
Biovail Corporation (NYSE, TSX: BVF) today announced that the Company’s
Board of Directors has declared a quarterly cash dividend of US$0.375
per share payable on April 6, 2009, to shareholders of record at the
close of business March 10, 2009. The ex-dividend date is March 6, 2009.
Upon payment of this dividend, Biovail will have distributed US$4.88 per
share to shareholders since implementing its dividend program in
December 2005.
Important Income-Tax Information for Canadian Resident Shareholders
Biovail Corporation designates the entire amount of this taxable
dividend to be an “eligible dividend” for purposes of the Income Tax Act
(Canada), as amended from time to time. This notice meets the
requirements of the Income Tax Act (Canada). Please contact your tax
advisor if you have any questions with regard to the designation of the
eligible dividend.
About Biovail Corporation
Biovail Corporation is a specialty pharmaceutical company engaged in the
formulation, clinical testing, registration, manufacture, and
commercialization of pharmaceutical products. The Company is focused on
the development and commercialization of medicines that address unmet
medical needs in niche specialty central nervous system (CNS) markets.
For more information about Biovail, visit the Company’s Web site at www.biovail.com.
For further information, please contact Nelson F. Isabel at 905-286-3000
or send inquiries to ir@biovail.com.
Source: Biovail Corporation
Biovail Corporation
Nelson F. Isabel, (905) 286-3000
Vice-President,
Investor Relations & Corporate Communications
|
